Abstract
In New South Wales, infection was
gazetted as a notifiable disease in 1998. Subsequently the
number of laboratory notifications has more than doubled
between 1999 and 2002, with 5,542 cases reported in 2002.
This article describes the findings of an enhanced surveillance
program based on the follow-up of notifications received by a
Sydney metropolitan public health unit.
